Glycolysis inhibits Foxp3 splicing variants containing exon 2 (Foxp3-E2) via the glycolytic enzyme enolase-1, and this finding was confirmed in T1D patients [72]. Here, FOXP3 is linked to type 1 diabetes mellitus.